Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Marsoni

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Medical and Pediatric Oncology|January 1, 1989
Treating childhood acute lymphoblastic leukaemia (ALL): summary of ten years' experience in Italy. ALL Steering Committee of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)G Paolucci, G Masera, V Vecchi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Early ovarian cancer and the icon trialsD Ghersi, M K Parmar, L A Stewart, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1980
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimensL Ottolenghi, L Morasca, S Marsoni, et al.
Cancer Treatment Reports|November 1, 1985
Tolerance to antineoplastic agents in children and adultsS Marsoni, R S Ungerleider, S B Hurson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Minimal guidelines for the monitoring of early clinical trials (phase I-II) in Europe under CRC/EORTC/NCI joint agreementC Arrigo, I J Koier, J G McVie, et al.
The New England Journal of Medicine|March 14, 1985
Etoposide (VP-16-213). Current status of an active anticancer drugP J O'Dwyer, B Leyland-Jones, M T Alonso, et al.
European Journal of Cancer|March 1, 1981
Vincristine and bleomycin do not interfere with infusional plasma levels of methotrexateI Ottolenghi, E Piazza, S Marsoni, et al.
Cancer Treatment Reports|January 1, 1987
Clinical drug development: an analysis of phase II trials, 1970-1985S Marsoni, D Hoth, R Simon, et al.
Investigational New Drugs|January 1, 1983
Spiromustine: a new agent entering clinical trialsD D Shoemaker, P J O'Dwyer, S Marsoni, et al.
Tumori|April 30, 1994
Patterns of care and survival in non small cell lung cancer: 15 years' experience in a general hospitalM Clerici, D Panvini, V Torri, et al.
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Medical and Pediatric Oncology|January 1, 1989
Treating childhood acute lymphoblastic leukaemia (ALL): summary of ten years' experience in Italy. ALL Steering Committee of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP)G Paolucci, G Masera, V Vecchi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Early ovarian cancer and the icon trialsD Ghersi, M K Parmar, L A Stewart, et al.
Biomedicine / [Publiee Pour L'A.A.I.C.I.G.]|October 1, 1980
Plasma levels of cyclophosphamide in patients under polychemotherapeutic regimensL Ottolenghi, L Morasca, S Marsoni, et al.
Cancer Treatment Reports|November 1, 1985
Tolerance to antineoplastic agents in children and adultsS Marsoni, R S Ungerleider, S B Hurson, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Minimal guidelines for the monitoring of early clinical trials (phase I-II) in Europe under CRC/EORTC/NCI joint agreementC Arrigo, I J Koier, J G McVie, et al.
The New England Journal of Medicine|March 14, 1985
Etoposide (VP-16-213). Current status of an active anticancer drugP J O'Dwyer, B Leyland-Jones, M T Alonso, et al.
European Journal of Cancer|March 1, 1981
Vincristine and bleomycin do not interfere with infusional plasma levels of methotrexateI Ottolenghi, E Piazza, S Marsoni, et al.
Cancer Treatment Reports|January 1, 1987
Clinical drug development: an analysis of phase II trials, 1970-1985S Marsoni, D Hoth, R Simon, et al.
Investigational New Drugs|January 1, 1983
Spiromustine: a new agent entering clinical trialsD D Shoemaker, P J O'Dwyer, S Marsoni, et al.
Tumori|April 30, 1994
Patterns of care and survival in non small cell lung cancer: 15 years' experience in a general hospitalM Clerici, D Panvini, V Torri, et al.
Pageof 7